Swart E.L., Zuideveld K.P., Jongh J.d., Danhof M., Thijs L.G. and Strack van Schijndel R.M., Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients, Eur J Clin Pharmacol., 62(3): 185-194., 2006. [Link to publication]
Swart E.L., Jongh J.d., Zuideveld K.P., Danhof M., Thijs L.G. and Strack van Schijndel R.J., Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration, Am J Kidney Dis., 45(2): 360-371., 2005. [Link to publication]
Ploeger B., Houwing N., Bom A., Zollinger D. and Danhof M., Reversal of rocuronium-induced neuromuscular block by cyclodextin ORG 25969: model development and validation. PAGE.(2004). [Link to publication]
Ploeger B., Ruigt G.S., Bom A., Houwing N., Iersel M.P.v. and Danhof M., PK-PD modelling of reversal of neuromuscular by a chemically optimised cyclodextrin. ASCPT.(2004).
Swart E.L., Zuideveld K.P., Jongh J.d., Danhof M., Thijs L.G. and Strack van Schijndel R.M., Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients, Br J Clin Pharmacol., 57(2): 135-145., 2004. [Link to publication]
Schaddelee M.P., Groenendaal D., Jongh J.d., Cleypool C.G., AP I.J., Boer A.G. d. and Danhof M., Population pharmacokinetic modeling of blood-brain barrier transport of synthetic adenosine A1 receptor agonists, J Pharmacol Exp Ther, 311(3): 1138-1146, 2004. [Link to publication]
Schaddelee M.P., Jongh J.d., Collins S.D., Boer A.G.d., Ijzerman A.P. and Danhof M., Population pharmacokinetic-pharmacodynamic modelling of the anti-hyperalgesic effect of 5’deoxy-N6-cylopentyladenosine in the mononeuropathic rat, Eur J Pharmacol, 504(1-2): 7-15, 2004. [Link to publication]
- « Previous
- 1
- 2
- 3
- 4